Table 2. HIV-RNA copy levels by time and treatment group.
| Time | ART | ART with MVC | ||
| HIV-RNA (Copies/mL) | N° of patientsundetectable (%) | HIV-RNA (Copies/mL) | N° of patients undetectable (%) | |
| Baseline | 15054 (99–711230) | 0/43 (0) | 14513 (77–917150) | 0/45 (0) |
| Week 4 | 49 (49–8785) | 27/42 (64) | 49 (49–1435) | 26/45 (58) |
| Week 12 | 49 (49–414678) | 33/42 (79) | 49 (49–51439) | 34/45 (76) |
| Week 24 | 49 (49–173753) | 35/42 (83) | 49 (49–32935) | 38/45 (84) |
| Week 36 | 49 (49–79798) | 32/37 (86) | 49 (49–314311) | 35/42 (83) |
| Week 48 | 49 (49–623999) | 33/35 (94) | 49 (49–71702) | 39/43 (91) |
Data is presented as median and range. 49 copies is the lower limit of detection of the assay, and it was written in the database to indicate that the HIV-RNA was undetectable.